SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Monte Rosa’s MRT-6160 Enters Phase 2 Trial

Monte Rosa’s MRT-6160 has entered a Phase 2 trial in psoriatic arthritis.

GLUE